Abstrakt: |
Hutchison China MediTech Limited (“Chi-Med”) (AIM/Nasdaq: HCM) announced today the closing of its underwritten public offering of American Depositary Shares ("ADSs") on the Nasdaq Global Select Market, previously announced by Chi-Med on October 24, 2017, October 25, 2017 and October 27, 2017 at a price of US$26.50 per ADS ("Offering"), raising gross proceeds of approximately US$301.3 million (before deducting underwriting discounts, commissions and offering expenses). [ABSTRACT FROM PUBLISHER] |